Evidence map›Paper›PMID 26269712›Full record

ArticleBiotechnology for biofuels2015

Expression of the Acidothermus cellulolyticus E1 endoglucanase in Caldicellulosiruptor bescii enhances its ability to deconstruct crystalline cellulose.

Daehwan Chung, Jenna Young, Minseok Cha, Roman Brunecky, Yannick J Bomble, Michael E Himmel, Janet Westpheling

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Characterization of the Biomass Degrading Enzyme GuxA fromInternational journal of molecular sciences · 2022
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daehwan ChungDepartment of Genetics, University of Georgia, Athens, GA USA ; Oak Ridge National Laboratory, The BioEnergy Science Center, Oak Ridge, TN USA.
Jenna YoungDepartment of Genetics, University of Georgia, Athens, GA USA ; Oak Ridge National Laboratory, The BioEnergy Science Center, Oak Ridge, TN USA.
Minseok ChaDepartment of Genetics, University of Georgia, Athens, GA USA ; Oak Ridge National Laboratory, The BioEnergy Science Center, Oak Ridge, TN USA.
Roman BruneckyNational Renewable Energy Laboratory, Biosciences Center, Golden, CO USA ; Oak Ridge National Laboratory, The BioEnergy Science Center, Oak Ridge, TN USA.
Yannick J BombleNational Renewable Energy Laboratory, Biosciences Center, Golden, CO USA ; Oak Ridge National Laboratory, The BioEnergy Science Center, Oak Ridge, TN USA.
Michael E HimmelNational Renewable Energy Laboratory, Biosciences Center, Golden, CO USA ; Oak Ridge National Laboratory, The BioEnergy Science Center, Oak Ridge, TN USA.
Janet WestphelingDepartment of Genetics, University of Georgia, Athens, GA USA ; Oak Ridge National Laboratory, The BioEnergy Science Center, Oak Ridge, TN USA.
University of Georgia · USNational Renewable Energy Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Caldicellulosiruptor bescii genome encodes a potent set of carbohydrate-active enzymes (CAZymes), found primarily as multi-domain enzymes that exhibit high cellulolytic and hemicellulolytic activity on and allow utilization of a broad range of substrates, including plant biomass without conventional pretreatment. CelA, the most abundant cellulase in the C. bescii secretome, uniquely combines a GH9 endoglucanase and a GH48 exoglucanase in one protein. The most effective commercial enzyme cocktails used in vitro to pretreat biomass are derived from fungal cellulases (cellobiohydrolases, endoglucanases and a β-d-glucosidases) that act synergistically to release sugars for microbial conversion. The C. bescii genome contains six GH5 domains in five different open reading frames. Four exist in multi-domain proteins and two as single catalytic domains. E1 is a GH5 endoglucanase reported to have high specific activity and simple architecture and is active at the growth temperature of C. bescii. E1 is an endo-1,4-β-glucanase linked to a family 2 carbohydrate-binding module shown to bind primarily to cellulosic substrates. We tested if the addition of this protein to the C. bescii secretome would improve its cellulolytic activity.

resultsIn vitro analysis of E1 and CelA shows synergistic interaction. The E1 gene from Acidothermus cellulolyticus was cloned and expressed in C. bescii under the transcriptional control of the C. bescii S-layer promoter, and secretion was directed by the addition of the C. bescii CelA signal peptide sequence. The vector was integrated into the C. bescii chromosome at a site previously showing no detectable detrimental consequence. Increased activity of the secretome of the strain containing E1 was observed on both carboxymethylcellulose (CMC) and Avicel. Activity against CMC increased on average 10.8 % at 65 °C and 12.6 % at 75 °C. Activity against Avicel increased on average 17.5 % at 65 °C and 16.4 % at 75 °C.

conclusionsExpression and secretion of E1 in C. bescii enhanced the cellulolytic ability of its secretome. These data agree with in vitro evidence that E1 acts synergistically with CelA to digest cellulose and offer the possibility of engineering additional enzymes for improved biomass deconstruction with the knowledge that C. bescii can express a gene from Acidothermus, and perhaps other heterologous genes, effectively.

Identifiers

PMID26269712
PMCPMC4533959
OpenAlexW2164565612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.